# FDA Inspection 1137067 - Eurofins Advantar Laboratories, Inc - March 05, 2021

Source: https://www.keypedia.com/records/fda_inspections/eurofins-advantar-laboratories-inc/4c81f24f-1321-4c4e-be89-e2be0585c02b
Source feed: FDA_Inspections

> FDA Inspection 1137067 for Eurofins Advantar Laboratories, Inc on March 05, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1137067
- Company Name: Eurofins Advantar Laboratories, Inc
- Inspection Date: 2021-03-05
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 960010 - 2016-02-03](https://www.keypedia.com/records/fda_inspections/eurofins-advantar-laboratories-inc/80fc5ccf-1c21-4ec7-9f7a-0bb3a2b7c058)

Company: https://www.keypedia.com/companies/eurofins-advantar-laboratories-inc/fe88e38f-0ce0-4e6e-a1bb-ed73634ac024

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c